Mahesh Yadav

Title: Mahesh Yadav: Innovator in Immunogenic Peptide Identification

Introduction

Mahesh Yadav is a prominent inventor based in San Bruno, CA (US). He has made significant contributions to the field of immunotherapy, particularly in the identification of disease-specific immunogenic peptides. With a total of 4 patents, his work is paving the way for advancements in personalized medicine.

Latest Patents

Yadav's latest patents focus on the identification of immunogenic mutant peptides using genomic, transcriptomic, and proteomic information. The methods he developed provide a series of selection steps to identify disease-specific immunogenic peptides. These immunogenic epitopes are particularly applicable for use in peptide-based immunotherapy, especially in cancer therapy. Furthermore, his methods can be performed in a high-throughput manner, serving as a means for personalized vaccine development and therapy. Alongside these methods, he has also provided compositions of immunogenic peptides and methods of treatment that incorporate these compositions.

Career Highlights

Throughout his career, Mahesh Yadav has worked with notable companies such as Genentech, Inc. and F. Hoffmann-La Roche AG. His experience in these leading organizations has contributed to his expertise in the field of immunotherapy and peptide research.

Collaborations

Yadav has collaborated with esteemed colleagues, including Patrick Lupardus and Jane Louise Grogan. These collaborations have further enriched his research and innovation in the field.

Conclusion

Mahesh Yadav's contributions to the identification of immunogenic peptides represent a significant advancement in cancer therapy and personalized medicine. His innovative methods and collaborations continue to influence the field positively.